MEA Blood Pressure Monitoring Devices Market

MEA Blood Pressure Monitoring Device Market Size (2022 to 2027)

The size of the Blood Pressure Monitoring Device Market in MEA was worth USD 275.06 Million in 2022 and is estimated to be growing at a CAGR of 8.11%, to reach USD 406.22 Million by 2027.

The demand for blood pressure monitoring devices in the Middle East and Africa is anticipated to rise during the forecast period, owing to the rising incidence of chronic diseases, high demand for proactive monitoring, rising healthcare expenditures, and the rapid increase in the geriatric population. According to a 2019 research report by the World Health Organization (WHO), more than 1.15 billion people worldwide suffer from lifestyle-related diseases such as hypertension, CVDs, COPD, obesity, diabetes, among others. Likewise, diabetes is also increasing at an alarming rate in the MEA region. According to WHO figures, more than 1.45 million deaths were directly linked to diabetes in 2019.

Rising awareness of the risks associated with hypertension can often lead to stroke, cardiovascular disorders, and kidney failure, ultimately leading to premature death. Hence, there is a critical need to regularly monitor blood pressure through digital and portable blood pressure monitors.  Additionally, the increase in awareness about various diseases and manufacturers continuously engaging in research and development (R&D) activities to improve the performance of these devices will drive market growth. The studied market is improving due to several variations in blood pressure monitors such as smart wearable gadgets and watches, compact and portable devices, and multi-user interfaces with the latest software to provide average blood pressure readings for each user. In addition, international and local government initiatives advocate the benefits of using home blood pressure monitoring devices to help people become more proactive towards good health.

However, lack of awareness in developing regions and inadequate reimbursement policies where the patients have to pay from their own money is anticipated to hamper the market growth of the MEA blood pressure monitoring devices.

This research report on the MEA blood pressure monitoring devices market has been segmented and sub-segmented into the following categories:

• By Type: Automated BP Monitors, Ambulatory BP Monitors, Sphygmomanometers (Mercury, Aneroid, Digital), BP Transducers, and BP Instruments Accessories.
• By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Among the MEA region, the Middle Eastern market is expected to dominate the MEA blood pressure monitoring devices market, with Saudi Arabia accounting for the largest revenue share during the studied timeline. This regional market will be supported by numerous favorable factors such as the increasing burden of chronic diseases such as hypertension, diabetes, cardiovascular disease, unhealthy lifestyle habits, a focus on health awareness and wellness, and the growing need for early disease diagnosis. The market revenue growth is further driven by the increasing trend of mHealth (mobile health), government investment in developing more advanced healthcare products and solutions, and rapid adoption of mobile blood pressure monitors and self-monitoring blood pressure devices in-home care settings. Digitized, sensor-based, and mobile blood pressure monitoring solutions for faster results, greater efficiency, and greater portability, giving more significant market opportunities.

Regional markets in the United Arab Emirates, Egypt, and South Africa are estimated to grow at a healthy growth rate owing to the rising trend of mHealth, rapid increase in aging population, availability and adoption of the latest BP monitoring devices, and increasing use of smart blood pressure monitoring solutions are other factors contributing to the growth of these markets.

KEY MARKET PLAYERS:

Companies playing an influential role in the MEA blood pressure monitoring devices market profiled in this report are GE Healthcare, Welch Allyn, A&D Medical Inc., SunTech Medical, Rossmax International Ltd, Spacelabs Healthcare Inc. Panasonic Corporation, Philips Healthcare, Contec Medical Systems Co. Ltd, Omron Healthcare, and Microlife AG.